Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Iran Nuclear ‘Breakout Time’ Could Be Weeks

It is still up in the air whether Iran will choose to comply…
Read more

Biden Skewering Trump’s Affirmation of Israel’s Capital

President Biden, despite his promises to not do so, is beginning…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

600 Earthquakes at California-Mexico Border

Over 600 earthquakes have been recorded at the California-Mexico…
Read more